Patents by Inventor Alex SWARBRICK

Alex SWARBRICK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230085358
    Abstract: The present invention relates to methods for the classification and stratification of cells within tumour samples. In one aspect, the invention provides for methods for determining cell-type abundances in whole tumour samples and categorising these cell-type abundances into ecotypes.
    Type: Application
    Filed: June 24, 2022
    Publication date: March 16, 2023
    Inventors: Ghamdan Abdulqawi Al-Eryani, Daniel Lee Roden, Sunny Ziyang Wu, Alex Swarbrick
  • Publication number: 20220415434
    Abstract: The present invention relates to methods for the classification and stratification of cells within tumours. In one aspect, the invention provides methods for classifying cancer cells into intrinsic cancer subtypes, as well as for diagnosing, prognosing and evaluating a response to therapy for patients afflicted with cancer.
    Type: Application
    Filed: June 24, 2022
    Publication date: December 29, 2022
    Inventors: Charles Perou, Daniel Lee Roden, Sunny Ziyang Wu, Aatish Thennaven, Alex Swarbrick, Ghamdan Abdulqawi Al-Eryani
  • Publication number: 20190300882
    Abstract: This disclosure relates to RNA interference (RNAi) reagents for treatment of neuroblastoma, compositions comprising same, and use thereof to treat individuals suffering from neuroblastoma as a monotherapy or in combination with a chemotherapeutic agent. In particular, the present disclosure relates to microRNAs (miRNAs) which affect viability of neuroblastoma cells.
    Type: Application
    Filed: June 7, 2017
    Publication date: October 3, 2019
    Applicants: GARVAN INSTITUTE OF MEDICAL RESEARCH, PETER MACCALLUM CANCER INSTITUTE
    Inventors: Alex SWARBRICK, Iva NIKOLIC, Kaylene SIMPSON